Australia markets closed

Tonix Pharmaceuticals Holding Corp. (TPM0.F)

Frankfurt - Frankfurt Delayed price. Currency in USD
Add to watchlist
0.0000-2.8200 (-100.00%)
At close: 08:25AM CEST
Currency in

Valuation measures4

Market cap (intra-day) 21.13M
Enterprise value 15.75M
Trailing P/E 0.30
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.25
Enterprise value/revenue 3.95
Enterprise value/EBITDA -0.13

Trading information

Stock price history

Beta (5Y monthly) 2.23
52-week change 3-30.15%
S&P500 52-week change 322.38%
52-week high 34.5000
52-week low 32.4150
50-day moving average 32.8200
200-day moving average 32.8200

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 558.61M
Implied shares outstanding 621.81M
Float 884.49M
% held by insiders 10.01%
% held by institutions 119.87%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:6.25
Last split date 310 May 2023

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-723.18%

Management effectiveness

Return on assets (ttm)-38.93%
Return on equity (ttm)-74.61%

Income statement

Revenue (ttm)7.77M
Revenue per share (ttm)0.46
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -114.09M
Net income avi to common (ttm)-116.66M
Diluted EPS (ttm)-12.3900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)24.95M
Total cash per share (mrq)0.29
Total debt (mrq)9.81M
Total debt/equity (mrq)9.30%
Current ratio (mrq)2.53
Book value per share (mrq)1.80

Cash flow statement

Operating cash flow (ttm)-102M
Levered free cash flow (ttm)-82M